(Q42045193)

English

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)

scientific article published on June 1, 1991

Statements

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053) (English)
1219-1222

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit